Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients

(2009) J D Barros-Silva et al.   BRITISH JOURNAL OF CANCER

HER-2 amplification is highly homogenous in gastric cancer

(2009) Andreas H. Marx et al.   HUMAN PATHOLOGY

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

(2009) Sejal S. Shah et al.   HUMAN PATHOLOGY

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

(2008) C. Gravalos et al.   ANNALS OF ONCOLOGY

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY

Polysomy 17 and HER-2 Amplification: True, True, and Unrelated

(2008) Carol L. Rosenberg   JOURNAL OF CLINICAL ONCOLOGY